954 related articles for article (PubMed ID: 30227605)
41. Non-coding landscapes of colorectal cancer.
Ragusa M; Barbagallo C; Statello L; Condorelli AG; Battaglia R; Tamburello L; Barbagallo D; Di Pietro C; Purrello M
World J Gastroenterol; 2015 Nov; 21(41):11709-39. PubMed ID: 26556998
[TBL] [Abstract][Full Text] [Related]
42. Pathogenetic and clinical relevance of microRNAs in colorectal cancer.
Valeri N; Croce CM; Fabbri M
Cancer Genomics Proteomics; 2009; 6(4):195-204. PubMed ID: 19656996
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.
Qiu Z; Guo W; Wang Q; Chen Z; Huang S; Zhao F; Yao M; Zhao Y; He X
Gastroenterology; 2015 Nov; 149(6):1587-1598.e11. PubMed ID: 26248089
[TBL] [Abstract][Full Text] [Related]
44. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
Yamamoto H; Mori M
Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
[TBL] [Abstract][Full Text] [Related]
45. The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer.
Liu Y; Chen X; Cheng R; Yang F; Yu M; Wang C; Cui S; Hong Y; Liang H; Liu M; Zhao C; Ding M; Sun W; Liu Z; Sun F; Zhang C; Zhou Z; Jiang X; Chen X
Mol Cancer; 2018 Jan; 17(1):11. PubMed ID: 29351796
[TBL] [Abstract][Full Text] [Related]
46. The pathological role of microRNAs and inflammation in colon carcinogenesis.
Zhang L; Fan XM
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):174-9. PubMed ID: 25154001
[TBL] [Abstract][Full Text] [Related]
47. Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.
Khalafizadeh A; Hashemizadegan SD; Shokri F; Bakhshinejad B; Jabbari K; Motavaf M; Babashah S
J Cell Mol Med; 2024 Apr; 28(7):e18197. PubMed ID: 38506091
[TBL] [Abstract][Full Text] [Related]
48. MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis.
Hur K
BMB Rep; 2015 Apr; 48(4):217-22. PubMed ID: 25603797
[TBL] [Abstract][Full Text] [Related]
49. A Review on Theragnostic Applications of Micrornas and Long Non- Coding RNAs in Colorectal Cancer.
Jothimani G; Sriramulu S; Chabria Y; Sun XF; Banerjee A; Pathak S
Curr Top Med Chem; 2018; 18(30):2614-2629. PubMed ID: 30582478
[TBL] [Abstract][Full Text] [Related]
50. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
51. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer.
Cekaite L; Eide PW; Lind GE; Skotheim RI; Lothe RA
Oncotarget; 2016 Feb; 7(6):6476-505. PubMed ID: 26623728
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
53. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
54. Noncoding RNA and colorectal cancer: its epigenetic role.
Kita Y; Yonemori K; Osako Y; Baba K; Mori S; Maemura K; Natsugoe S
J Hum Genet; 2017 Jan; 62(1):41-47. PubMed ID: 27278790
[TBL] [Abstract][Full Text] [Related]
55. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients.
Qi P; Xu MD; Ni SJ; Shen XH; Wei P; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Mol Carcinog; 2015 Sep; 54(9):742-50. PubMed ID: 24519959
[TBL] [Abstract][Full Text] [Related]
56. Transcriptome and Gene Fusion Analysis of Synchronous Lesions Reveals lncMRPS31P5 as a Novel Transcript Involved in Colorectal Cancer.
Panza A; Castellana S; Biscaglia G; Piepoli A; Parca L; Gentile A; Latiano A; Mazza T; Perri F; Andriulli A; Palmieri O
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992457
[TBL] [Abstract][Full Text] [Related]
57. Integrated analysis of long non-coding RNAs in human colorectal cancer.
Chen X; Liu B; Yang R; Guo Y; Li F; Wang L; Hu H
Oncotarget; 2016 Apr; 7(17):23897-908. PubMed ID: 27004403
[TBL] [Abstract][Full Text] [Related]
58. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells.
Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C
Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025
[TBL] [Abstract][Full Text] [Related]
59. The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer.
Huang W; Tian Y; Dong S; Cha Y; Li J; Guo X; Yuan X
Oncol Rep; 2017 Sep; 38(3):1402-1410. PubMed ID: 28731158
[TBL] [Abstract][Full Text] [Related]
60. Non-coding RNAs as Biomarkers for Survival in Colorectal Cancer Patients.
Andrabi MQ; Kesavan Y; Ramalingam S
Curr Aging Sci; 2024; 17(1):5-15. PubMed ID: 36733201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
